Trump strikes deal with Eli Lilly, Novo Nordisk
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg |…
Mark Cuban tries to shake up biosimilar pricing with a version of J&J’s Stelara
In its latest bid to shake up the prescription drug market, the Mark Cuban Cost Plus Drug Company…
Omada Health to start prescribing GLP-1s, other obesity medications
The Omada Health logo is displayed on a smartphone screen. Sopa Images | Lightrocket | Getty Images Virtual…
New FDA priority review vouchers go to Lilly, Novo, Vertex
WASHINGTON — The Food and Drug Administration on Thursday announced the second batch of companies being granted a “Commissioner’s…
Trump seeks lower prices for Wegovy, Zepbound
President Donald Trump announces plan to expand IVF access President Donald Trump announced a plan to expand IVF…
Teva recalls blood pressure medication over cancer-causing chemicals
New guidelines reveal how to lower blood pressure The American Heart Association and the American College of Cardiology…
Tokushima company develops bear repellent spray amid record attack numbers
As Japan grapples with a record number of fatal bear attacks, a small company in Tokushima Prefecture has…
Pfizer files second lawsuit against Novo Nordisk, Metsera
A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California,…
Eli Lilly (LLY) earnings Q3 2025
David Ricks, chief executive officer of Eli Lilly & Co., during a news conference at Generation Park in…
Bayer’s Lynkuet™ (elinzanetant) approved in the U.S. for treatment of moderate to severe vasomotor symptoms due to menopause
Berlin, October 24, 2025 – Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved…
Menopause symptoms disrupt daily life, but few women get treatment
A new study from Mayo Clinic underscores the widespread impact of menopause symptoms on midlife women – and…
Is Your Medication Made in a Contaminated Factory? The FDA Won’t Tell You
ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like…